Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
53,583,544
-
Total 13F shares
-
30,594,457
-
Share change
-
+1,862,282
-
Total reported value
-
$170,412,284
-
Put/Call ratio
-
0.46%
-
Price per share
-
$5.57
-
Number of holders
-
62
-
Value change
-
+$10,328,621
-
Number of buys
-
27
-
Number of sells
-
20
Institutional Holders of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) as of Q4 2024
As of 31 Dec 2024,
ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,594,457 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., SUVRETTA CAPITAL MANAGEMENT, LLC, Nantahala Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, Western Standard LLC, VANGUARD GROUP INC, Vivo Capital, LLC, Rosalind Advisors, Inc., Laurion Capital Management LP, and 683 Capital Management, LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.